Clinical Trial Update: Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Cefepime/VNRX-5133 for complicated urinary tract infections, including acute pyelonephritis; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyelonephritis
• Urinary Tract Infection

Drugs mentioned

• Cefepime/VNRX-5133 (cefepime + VNRX-5133)

Snippet

Sponsor: Venatorx Pharmaceuticals, Inc. | Conditions: Urinary Tract Infections, Acute Pyelonephritis | Phase 3 | Status: COMPLETED | Results posted: 2024-05-29